SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001193125-19-291076
Filing Date
2019-11-13
Accepted
2019-11-13 16:41:33
Documents
5
Period of Report
2019-11-13
Items
Item 7.01: Regulation FD Disclosure
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K d834294d8k.htm 8-K 20769
2 EX-99.1 d834294dex991.htm EX-99.1 28557
3 EX-99.2 d834294dex992.htm EX-99.2 15726
4 GRAPHIC g834294g91c06.jpg GRAPHIC 3398
5 GRAPHIC g834294img1.jpg GRAPHIC 858750
  Complete submission text file 0001193125-19-291076.txt   1254101
Mailing Address 200 SMITH STREET WALTHAM MA 02451
Business Address 200 SMITH STREET WALTHAM MA 02451 781-209-6400
Deciphera Pharmaceuticals, Inc. (Filer) CIK: 0001654151 (see all company filings)

IRS No.: 200299725 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-38219 | Film No.: 191214562
SIC: 2834 Pharmaceutical Preparations